Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Small Molecule Drug Discovery
        Genomic sequencing paves the way for better antiviral treatments.
            March 27, 2024 -
            2 min read
          
          
         
       
      Small Molecule Drug Discovery
        Accelerating vaccine development for the novel infectious disease with pseudoviruses.
            March 27, 2024 -
            2 min read
          
          
         
      Disease Research, Infectious Diseases
        How a SARS-CoV-2 infection can impact our reproductive health.
            March 26, 2024 -
            6 min read
          
          
         
      Biologics
        Bispecific antibodies: successes, challenges, and strategies.
            March 26, 2024 -
            3 min read
          
          
         
      Cancer
        Can tumors be reverse-engineered to produce a local-acting ‘vaccine’?
            March 25, 2024 -
            2 min read
          
          
         
      Disease Research, Infectious Diseases
        Could boosting autophagy with host-directed therapies help control TB infection?
            March 25, 2024 -
            2 min read
          
          
         
      Small Molecule Drug Discovery
        Researchers identify novel immunotherapeutic compound targeting key cancer pathway.
            March 25, 2024 -
            2 min read
          
          
         
      Small Molecule Drug Discovery
        SARS-CoV-2 protease inhibitors: an attractive approach for treating COVID-19.
            March 25, 2024 -
            3 min read
          
          
         
      Small Molecule Drug Discovery
        Managing the data deluge of high-content screening workflows.
            March 25, 2024 -
            3 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  